explore -WSS

explore

author：leisure time 2025-10-02 11:10:36 - browse：896

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Risky weight loss products often used by teens globally, per study

Wikipedia

WSS

EQRx, failed developer of low

What the US credit downgrade means for the economy, your finances

EQRx, failed developer of low

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

As JPM 2024 winds down, some health tech firms project optimism

The SUPPORT Act is critical to fighting the opioid crisis

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

National panel will explore requiring free Covid tests

United colonoscopy coverage change 'may cost lives,' doctors say

5 important ways Henrietta Lacks changed medical science

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Virginia high school admissions case could be legal follow

Mitch McConnell episode has important public health takeaway

Tori Bowie and the unacceptable rates of Black maternal death

EQRx, failed developer of low

knowledge

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Scientists inch closer to single

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Scientists inch closer to single

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

New menopause drug shows promise in relief for hot flashes

focus

focus

Wikipedia

hotspot